{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,20]],"date-time":"2026-05-20T17:06:44Z","timestamp":1779296804253,"version":"3.51.4"},"reference-count":45,"publisher":"Elsevier BV","issue":"8","license":[{"start":{"date-parts":[[2007,8,1]],"date-time":"2007-08-01T00:00:00Z","timestamp":1185926400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Clinical Therapeutics"],"published-print":{"date-parts":[[2007,8]]},"DOI":"10.1016\/j.clinthera.2007.08.023","type":"journal-article","created":{"date-parts":[[2007,10,4]],"date-time":"2007-10-04T14:45:34Z","timestamp":1191509134000},"page":"1579-1590","source":"Crossref","is-referenced-by-count":45,"title":["Efficacy and Safety of Inhaled Zanamivir in the Prevention of Influenza in Community-Dwelling, High-Risk Adult and Adolescent Subjects: A 28-day, Multicenter, Randomized, Double-Blind, Placebo-Controlled Trial"],"prefix":"10.1016","volume":"29","author":[{"given":"Craig","family":"LaForce","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Choy Y.","family":"Man","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Frederick W.","family":"Henderson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Janet E.","family":"McElhaney","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"suffix":"Jr.","given":"Frank C.","family":"Hampel","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Robert","family":"Bettis","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Laila","family":"Kudule","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Julia","family":"Harris","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Philip","family":"Yates","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Margaret","family":"Tisdale","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alison","family":"Webster","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.clinthera.2007.08.023_bib1","series-title":"Textbook of Influenza","year":"1998"},{"key":"10.1016\/j.clinthera.2007.08.023_bib2","first-page":"1","article-title":"Prevention and control of influenza: Recommendations of the Advisory Committee on Immunization Practices (ACIP)","volume":"55","author":"Smith","year":"2006","journal-title":"MMWR Morb Mortal Wkly ReD"},{"key":"10.1016\/j.clinthera.2007.08.023_bib3","doi-asserted-by":"crossref","first-page":"1333","DOI":"10.1001\/jama.292.11.1333","article-title":"Influenza- associated hospitalizations in the United States","volume":"292","author":"Thompson","year":"2004","journal-title":"JAMA"},{"key":"10.1016\/j.clinthera.2007.08.023_bib4","doi-asserted-by":"crossref","first-page":"712","DOI":"10.2105\/AJPH.77.6.712","article-title":"Impact of influenza epidemics on mortality in the United States from October 1972 to May 1985","volume":"77","author":"Lui","year":"1987","journal-title":"AmJ Pubfic Health"},{"key":"10.1016\/j.clinthera.2007.08.023_bib5","doi-asserted-by":"crossref","first-page":"1473","DOI":"10.1128\/AAC.37.7.1473","article-title":"4-Guanidino-2,4- dideoxy-2,3-dehydro-N-acetylneuraminic acid is a highly effective inhibitor of both the sialidase (neuraminidase) and of growth of a wide range of influenza A and B viruses in vitro","volume":"37","author":"Woods","year":"1993","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.clinthera.2007.08.023_bib6","first-page":"695","article-title":"2,3-Didehydro-2,4-dideoxy-4- guanidino-N-acetyI-D neuraminic acid (4-guanidino- NeuSAc2en) is a slow-binding inhibitor of sialidase from both influenza A virus and influenza B virus","volume":"36","author":"Hart","year":"1995","journal-title":"Biochem Mol Biol Int"},{"key":"10.1016\/j.clinthera.2007.08.023_bib7","doi-asserted-by":"crossref","first-page":"2264","DOI":"10.1128\/AAC.47.7.2264-2272.2003","article-title":"Neuraminidase sequence analysis and susceptibilities of influenza virus clinical isolates to zanamivir and oseltamivir","volume":"47","author":"McKimm-Breschkin","year":"2003","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.clinthera.2007.08.023_bib8","doi-asserted-by":"crossref","first-page":"1216","DOI":"10.1128\/AAC.45.4.1216-1224.2001","article-title":"Efficacy of zanamivir against avian influenza A viruses that possess genes encoding HSN1 internal proteins and are pathogenic in mammals","volume":"45","author":"Leneva","year":"2001","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.clinthera.2007.08.023_bib9","doi-asserted-by":"crossref","first-page":"1363","DOI":"10.1056\/NEJMra050740","article-title":"Neuraminidase inhibitors for influenza","volume":"353","author":"Moscona","year":"2005","journal-title":"N Engl J Med"},{"issue":"Suppl B","key":"10.1016\/j.clinthera.2007.08.023_bib10","first-page":"23","article-title":"Randomized, placebo-controlled studies of inhaled zanamivir in the treatment of influenza A and B: Pooled efficacy analysis","volume":"44","author":"Manta","year":"1999","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.clinthera.2007.08.023_bib11","doi-asserted-by":"crossref","first-page":"1877","DOI":"10.1016\/S0140-6736(98)10190-3","article-title":"Randomized trial of efficacy and safety of inhaled zanamivir in treatment of influenza A and B virus infections [published corrections appear in Lancet. 1999;353:504 and Lancet. 1999;353: 1104]","volume":"352","year":"1999","journal-title":"Lancet"},{"key":"10.1016\/j.clinthera.2007.08.023_bib12","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1053\/jinf.1999.0602","article-title":"Clinical efficacy and safety of the orally inhaled neuraminidase inhibitor zanamivir in the treatment of influenza: A randomized, double- blind, placebo-controlled European study","volume":"40","author":"Makela","year":"2000","journal-title":"J Infect"},{"key":"10.1016\/j.clinthera.2007.08.023_bib13","doi-asserted-by":"crossref","first-page":"410","DOI":"10.1097\/00006454-200005000-00005","article-title":"Zanamivir For treatment of symptomatic influenza A and B infection in children five to twelve years of age: A randomized controlled trial","volume":"19","author":"Hedrick","year":"2000","journal-title":"J Pediatr Infect Dis"},{"key":"10.1016\/j.clinthera.2007.08.023_bib14","doi-asserted-by":"crossref","first-page":"1282","DOI":"10.1056\/NEJM200011023431801","article-title":"Inhaled zanamivir for the prevention of influenza in families","volume":"343","author":"Hayden","year":"2000","journal-title":"N Engl J Med."},{"key":"10.1016\/j.clinthera.2007.08.023_bib15","doi-asserted-by":"crossref","first-page":"1582","DOI":"10.1086\/345722","article-title":"Zanamivir prophylaxis: An effective strategy for the prevention of influenza types A and B within households","volume":"186","author":"Monto","year":"2002","journal-title":"J Infect Dis"},{"key":"10.1016\/j.clinthera.2007.08.023_bib16","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1001\/jama.282.1.31","article-title":"Zanamivir in the prevention of influenza among healthy adults: A randomized controlled trial","volume":"282","author":"Monto","year":"1999","journal-title":"JAMA"},{"key":"10.1016\/j.clinthera.2007.08.023_bib18","series-title":"Clinical Virology Manual","first-page":"31","article-title":"Primaryisolation of viruses","author":"Landry","year":"1986"},{"key":"10.1016\/j.clinthera.2007.08.023_bib19","doi-asserted-by":"crossref","first-page":"2076","DOI":"10.1128\/JCM.35.8.2076-2082.1997","article-title":"Multiplex reverse transcription-PCR for surveillance of influenza A and B viruses in England and Wales in 1995 and 1996","volume":"35","author":"Ellis","year":"1997","journal-title":"J Clin Microbiol"},{"key":"10.1016\/j.clinthera.2007.08.023_bib20","doi-asserted-by":"crossref","first-page":"2990","DOI":"10.1128\/JCM.36.10.2990-2995.1998","article-title":"Multiplex PCR for typing and subtyping influenza and respiratory syncytial viruses","volume":"36","author":"Stockton","year":"1998","journal-title":"J Clin Microbiol"},{"key":"10.1016\/j.clinthera.2007.08.023_bib21","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1084\/jem.75.1.49","article-title":"The quantitative determination of influenza virus and anti-bodies by means of red cell agglutination","volume":"75","author":"Hirst","year":"1942","journal-title":"J Exp Med"},{"key":"10.1016\/j.clinthera.2007.08.023_bib22","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1006\/viro.1999.0058","article-title":"In vitro selection and charac- terisation of influenza B\/Beijing\/I\/ 87 isolates with altered susceptibili- ty to zanamivir","volume":"265","author":"Barnett","year":"1999","journal-title":"Virology"},{"key":"10.1016\/j.clinthera.2007.08.023_bib23","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1128\/AAC.44.1.78-87.2000","article-title":"Zanamivir susceptibility monitoring and characterization of influenza virus clinical isolates obtained during phase II clinical efficacy studies","volume":"44","author":"Barnett","year":"2000","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.clinthera.2007.08.023_bib24","doi-asserted-by":"crossref","first-page":"2737","DOI":"10.1099\/0022-1317-73-10-2737","article-title":"Antigenic and genetic characterization of the haemagglutinins of recent cocirculating strains of influenza B virus","volume":"73","author":"Rota","year":"1992","journal-title":"J Gen Virol"},{"key":"10.1016\/j.clinthera.2007.08.023_bib25","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1016\/0197-2456(93)90003-V","article-title":"Fixing the number of events in large comparative trials with low event rates: A binomial approach","volume":"14","author":"Shuster","year":"1993","journal-title":"Control Clin Trials"},{"key":"10.1016\/j.clinthera.2007.08.023_bib27","first-page":"471","article-title":"Point and interval estimation of the common odds ratio in the combination of 2 x 2 tables with fixed marginals","volume":"57","author":"Gart","year":"1970","journal-title":"Biometrika"},{"key":"10.1016\/j.clinthera.2007.08.023_bib28","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1093\/biomet\/53.1-2.213","article-title":"Asimple example of a comparison involving quanta","volume":"53","author":"Cox","year":"1966","journal-title":"Biometrika"},{"key":"10.1016\/j.clinthera.2007.08.023_bib29","doi-asserted-by":"crossref","first-page":"366","DOI":"10.1038\/289366a0","article-title":"Structure of the haemagglutinin membrane glycoprotein of influenza virus at 3A resolution","volume":"289","author":"Wilson","year":"1981","journal-title":"Nature"},{"key":"10.1016\/j.clinthera.2007.08.023_bib30","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1038\/303041a0","article-title":"Structure of the catalytic and antigenic sites in influenza virus neuraminidase","volume":"303","author":"Colman","year":"1983","journal-title":"Nature"},{"key":"10.1016\/j.clinthera.2007.08.023_bib31","doi-asserted-by":"crossref","first-page":"1655","DOI":"10.1001\/jama.284.13.1655","article-title":"Effectiveness and cost-benefit of influenza vaccination of healthy working adults: A randomized controlled trial","volume":"284","author":"Bridges","year":"2000","journal-title":"JAMA"},{"key":"10.1016\/j.clinthera.2007.08.023_bib32","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1093\/oxfordjournals.aje.a114809","article-title":"Efficacy of sequential annual vaccination with inactivated influenza virus vaccine","volume":"127","author":"Keitel","year":"1988","journal-title":"Am J Epidemiol"},{"key":"10.1016\/j.clinthera.2007.08.023_bib33","doi-asserted-by":"crossref","first-page":"1336","DOI":"10.1056\/NEJM199910283411802","article-title":"Use of the selective oral neuraminidase inhibitor oseltamivir to prevent influenza","volume":"341","author":"Hayden","year":"1999","journal-title":"N Engl J Med."},{"key":"10.1016\/j.clinthera.2007.08.023_bib34","doi-asserted-by":"crossref","first-page":"1025","DOI":"10.1046\/j.1532-5415.2001.49204.x","article-title":"Long-term use ofoseltamivir for the prophylaxis of influenza in a vaccinated frail older population","volume":"49","author":"Peters","year":"2001","journal-title":"JAm Geriatr Soc"},{"key":"10.1016\/j.clinthera.2007.08.023_bib35","doi-asserted-by":"crossref","first-page":"1341","DOI":"10.1136\/bmj.308.6940.1341","article-title":"Influenza: Diagnosis, management, and prophylaxis","volume":"308","author":"Wiselka","year":"1994","journal-title":"BMJ"},{"key":"10.1016\/j.clinthera.2007.08.023_bib36","series-title":"Options for the Control of Influenza","first-page":"155","article-title":"Experience in the use and efficacy of inactivated influenza vaccine in nursing homes","author":"Arden","year":"1986"},{"key":"10.1016\/j.clinthera.2007.08.023_bib37","first-page":"304","article-title":"Estimated influenza vaccination coverage among adults and children- United States, September 1, 2004\u2013January 31, 2005","volume":"54","year":"2005","journal-title":"MMWR Morb MortM Wkly Rep"},{"key":"10.1016\/j.clinthera.2007.08.023_bib38","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1056\/NEJM198307073090103","article-title":"Cytotoxic T-cell immunity to influenza","volume":"309","author":"McMichael","year":"1983","journal-title":"N Engl J Med"},{"key":"10.1016\/j.clinthera.2007.08.023_bib39","first-page":"466","article-title":"Update: Influenza activity-United States and worldwide, 2000\u201301 season, and composition of the 2001\u201302 influenza vaccine","volume":"50","year":"2001","journal-title":"MMWR Morb Mortal Wkly Rep."},{"key":"10.1016\/j.clinthera.2007.08.023_bib40","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1001\/jama.289.2.179","article-title":"Mortality associated with influenza and respiratory syncytial virus in the United States","volume":"289","author":"Thompson","year":"2003","journal-title":"JAMA"},{"key":"10.1016\/j.clinthera.2007.08.023_bib41","doi-asserted-by":"crossref","first-page":"2633","DOI":"10.1056\/NEJMp058291","article-title":"Oseltamivir resistance\u2014 disabling our influenza defenses","volume":"353","author":"Moscona","year":"2005","journal-title":"N EnglJ Med"},{"key":"10.1016\/j.clinthera.2007.08.023_bib42","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1016\/j.jamda.2005.08.006","article-title":"Inhaled zanamivir versus rimantadine for the control of influenza in a highly vaccinated long-term care population","volume":"6","author":"Gravenstein","year":"2005","journal-title":"J Am Med Dir Assoc"},{"key":"10.1016\/j.clinthera.2007.08.023_bib43","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0166-3542(00)00103-0","article-title":"Resistance of influenza viruses to neuraminidase inhibitors-a review","volume":"47","author":"McKimm-Breschkin","year":"2000","journal-title":"Antiviral Res"},{"key":"10.1016\/j.clinthera.2007.08.023_bib44","doi-asserted-by":"crossref","first-page":"1557","DOI":"10.1086\/314440","article-title":"Evidence for zanamivir resistance in an immuno-compromised child infected with influenza B virus","volume":"178","author":"Gubareva","year":"1998","journal-title":"J Infect Dis"},{"key":"10.1016\/j.clinthera.2007.08.023_bib45","doi-asserted-by":"crossref","first-page":"735","DOI":"10.1016\/S0969-2126(98)00075-6","article-title":"Drug design against a shifting target: A structural basis for resistance to inhibitors in a variant of influenza virus neuraminidase","volume":"6","author":"Varghese","year":"1998","journal-title":"Structure"},{"key":"10.1016\/j.clinthera.2007.08.023_bib46","doi-asserted-by":"crossref","first-page":"1592","DOI":"10.1086\/314515","article-title":"Characterization of human influenza A\/Hong Hong\/ 156\/97 (HSN1) virus in a mouse model and protective effect of zanamivir on HSN1 infection in mice","volume":"178","author":"Gubareva","year":"1998","journal-title":"J Infect Dis"},{"key":"10.1016\/j.clinthera.2007.08.023_bib47","doi-asserted-by":"crossref","first-page":"1108","DOI":"10.1038\/4371108a","article-title":"Avian flu: Isolation of drug-resistant HSN1 virus [published correction appears in Nature. 2005;438:754]","volume":"437","author":"Le","year":"2005","journal-title":"Nature"}],"container-title":["Clinical Therapeutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0149291807002585?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0149291807002585?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,4,27]],"date-time":"2020-04-27T01:24:54Z","timestamp":1587950694000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0149291807002585"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2007,8]]},"references-count":45,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2007,8]]}},"alternative-id":["S0149291807002585"],"URL":"https:\/\/doi.org\/10.1016\/j.clinthera.2007.08.023","relation":{},"ISSN":["0149-2918"],"issn-type":[{"value":"0149-2918","type":"print"}],"subject":[],"published":{"date-parts":[[2007,8]]}}}